• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭:来自近期临床研究的新视角。

Heart failure with preserved ejection fraction: insights from recent clinical researches.

机构信息

Division of Cardiology, Korea University Anam Hospital, Seoul, Korea.

出版信息

Korean J Intern Med. 2020 May;35(3):514-534. doi: 10.3904/kjim.2020.104. Epub 2020 Apr 29.

DOI:10.3904/kjim.2020.104
PMID:32392659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7214356/
Abstract

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society. Patients with HFpEF present with significant symptoms, including exercise intolerance, impaired quality of life, and have a poor prognosis as well as frequent hospitalization and increased mortality compared with HF with reduced ejection fraction. The concept of HFpEF is still evolving and may be a virtual complex rather than a real systemic disorder. Thus, beyond solely targeting cardiac abnormalities management strategies need to be extended, such as left ventricular diastolic dysfunction. In this review, we examine new diagnostic algorithms, pathophysiology, current management status, and ongoing trials based on heterogeneous pathophysiology and etiology in HFpEF.

摘要

射血分数保留的心力衰竭(HFpEF)占心力衰竭病例的近一半,随着老龄化社会的到来,其发病率可能会增加。HFpEF 患者有明显的症状,包括运动不耐受、生活质量受损,与射血分数降低的心力衰竭患者相比,预后较差,住院频率更高,死亡率也更高。HFpEF 的概念仍在不断发展,它可能是一种虚拟的复杂疾病,而不是真正的系统性疾病。因此,除了单纯针对心脏异常进行治疗外,还需要扩展管理策略,如左心室舒张功能障碍。在这篇综述中,我们根据 HFpEF 异质性的病理生理学和病因,检查了新的诊断算法、病理生理学、当前的管理现状和正在进行的试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7acd/7214356/e8359781ff46/kjim-2020-104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7acd/7214356/e2397aafd7b7/kjim-2020-104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7acd/7214356/e8359781ff46/kjim-2020-104f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7acd/7214356/e2397aafd7b7/kjim-2020-104f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7acd/7214356/e8359781ff46/kjim-2020-104f2.jpg

相似文献

1
Heart failure with preserved ejection fraction: insights from recent clinical researches.射血分数保留的心力衰竭:来自近期临床研究的新视角。
Korean J Intern Med. 2020 May;35(3):514-534. doi: 10.3904/kjim.2020.104. Epub 2020 Apr 29.
2
Heart failure with preserved ejection fraction: New approaches to diagnosis and management.射血分数保留的心力衰竭:新的诊断和治疗方法。
Clin Cardiol. 2020 Feb;43(2):145-155. doi: 10.1002/clc.23321. Epub 2019 Dec 26.
3
Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction.老年综合征的演变:射血分数保留的心力衰竭的病理生理学与治疗
J Am Geriatr Soc. 2017 Nov;65(11):2431-2440. doi: 10.1111/jgs.15141.
4
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.射血分数保留的心力衰竭伴发心原性猝死:难以捉摸的靶点。
Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2.
5
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
6
Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.射血分数保留的心力衰竭:流行病学、病理生理学、表型、诊断及治疗方法
Turk Kardiyol Dern Ars. 2022 May;50(Supp1):S1-S34. doi: 10.5543/tkda.2022.S1.
7
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.心力衰竭伴左心室射血分数保留患者的超声心动图特征。
J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063.
8
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives.射血分数保留的心力衰竭中的免疫调节:现状与未来展望。
J Cardiovasc Transl Res. 2021 Feb;14(1):63-74. doi: 10.1007/s12265-020-10026-3. Epub 2020 May 22.
9
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management.射血分数保留的心力衰竭:诊断、机制与管理的最新概念
Heart. 2022 Aug 11;108(17):1342-1350. doi: 10.1136/heartjnl-2021-319605.
10
Heart Failure with Preserved Ejection Fraction-a Concise Review.射血分数保留的心力衰竭——简要综述。
Curr Cardiol Rep. 2020 Jul 9;22(9):82. doi: 10.1007/s11886-020-01349-3.

引用本文的文献

1
Quality of Life and Experience of Patients with Heart Failure with Preserved Ejection Fraction and Their Caregivers.射血分数保留的心力衰竭患者及其照顾者的生活质量与体验
J Clin Med. 2025 Jul 3;14(13):4715. doi: 10.3390/jcm14134715.
2
Relationship Between Epicardial Adipose Tissue and Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者中心外膜脂肪组织与心房颤动的关系
Cureus. 2025 Mar 19;17(3):e80827. doi: 10.7759/cureus.80827. eCollection 2025 Mar.
3
Important functions and molecular mechanisms of aquaporins family on respiratory diseases: potential translational values.

本文引用的文献

1
Sodium-glucose Co-transporters-2 Inhibitors and Heart Failure: State of the Art Review and Future Potentials.钠-葡萄糖协同转运蛋白2抑制剂与心力衰竭:现状综述及未来潜力
Int J Heart Fail. 2020 Jan 13;2(1):12-22. doi: 10.36628/ijhf.2019.0013. eCollection 2020 Jan.
2
Common Co-Morbidities in Heart Failure - Diabetes, Functional Mitral Regurgitation and Sleep Apnoea.心力衰竭常见的共病——糖尿病、功能性二尖瓣反流和睡眠呼吸暂停。
Int J Heart Fail. 2019 Oct 15;1(1):25-41. doi: 10.36628/ijhf.2019.0004. eCollection 2019 Oct.
3
Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
水通道蛋白家族在呼吸系统疾病中的重要功能及分子机制:潜在的转化价值
J Cancer. 2024 Oct 7;15(18):6073-6085. doi: 10.7150/jca.98829. eCollection 2024.
4
Current Insights and Future Directions in the Treatment of Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭治疗的现状与展望。
Int J Mol Sci. 2023 Dec 28;25(1):440. doi: 10.3390/ijms25010440.
5
Role of cardiac imaging in management of heart failure.心脏影像学在心力衰竭管理中的作用。
Korean J Intern Med. 2023 Sep;38(5):607-619. doi: 10.3904/kjim.2023.262. Epub 2023 Aug 29.
6
Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.三种独立的病理性应激源可导致射血分数保留型心力衰竭表型。
Am J Physiol Heart Circ Physiol. 2023 Apr 1;324(4):H443-H460. doi: 10.1152/ajpheart.00594.2022. Epub 2023 Feb 10.
7
HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction.HFA-PEFF 评分:在射血分数保留的心力衰竭中的预后价值。
Korean J Intern Med. 2022 Jan;37(1):96-108. doi: 10.3904/kjim.2021.272. Epub 2021 Dec 21.
8
Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review.是否有足够的证据支持心力衰竭患者改变饮食习惯?系统评价。
Korean J Intern Med. 2022 Jan;37(1):37-47. doi: 10.3904/kjim.2020.623. Epub 2021 Sep 6.
9
Challenges in the management of people with heart failure with preserved ejection fraction (HFpEF) in primary care: A qualitative study of general practitioner perspectives.基层医疗中射血分数保留的心力衰竭(HFpEF)患者管理面临的挑战:全科医生观点的定性研究。
Chronic Illn. 2022 Jun;18(2):410-425. doi: 10.1177/1742395320983871. Epub 2021 Jan 5.
射血分数保留的心房颤动和心力衰竭中左心房心肌病的治疗靶点
JAMA Cardiol. 2020 May 1;5(5):497-499. doi: 10.1001/jamacardio.2020.0136.
4
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.荟萃分析评价肾素-血管紧张素-醛固酮系统阻断对射血分数保留心力衰竭结局的影响。
Am J Cardiol. 2020 Apr 15;125(8):1187-1193. doi: 10.1016/j.amjcard.2020.01.009. Epub 2020 Jan 30.
5
Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.射血分数保留的心力衰竭患者的左心房功能:系统评价和荟萃分析。
Eur J Heart Fail. 2020 Mar;22(3):472-485. doi: 10.1002/ejhf.1643. Epub 2020 Jan 9.
6
Heart failure with preserved ejection fraction: New approaches to diagnosis and management.射血分数保留的心力衰竭:新的诊断和治疗方法。
Clin Cardiol. 2020 Feb;43(2):145-155. doi: 10.1002/clc.23321. Epub 2019 Dec 26.
7
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.β受体阻滞剂的使用与射血分数保留的心力衰竭患者心力衰竭住院和心血管疾病死亡率的关系:TOPCAT 试验的二次分析。
JAMA Netw Open. 2019 Dec 2;2(12):e1916598. doi: 10.1001/jamanetworkopen.2019.16598.
8
Medical Therapies for Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的医学治疗方法。
Hypertension. 2020 Jan;75(1):23-32. doi: 10.1161/HYPERTENSIONAHA.119.14057. Epub 2019 Dec 2.
9
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.沙库巴曲缬沙坦在心力衰竭射血分数谱中的应用。
Circulation. 2020 Feb 4;141(5):352-361. doi: 10.1161/CIRCULATIONAHA.119.044586. Epub 2019 Nov 17.
10
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.沙库巴曲缬沙坦与缬沙坦对射血分数保留心力衰竭女性与男性患者的影响:PARAGON-HF 研究的见解。
Circulation. 2020 Feb 4;141(5):338-351. doi: 10.1161/CIRCULATIONAHA.119.044491. Epub 2019 Nov 17.